Collegium Pharmaceutical, Inc. (COLL) vs Tilray Brands, Inc. (TLRY)
- Collegium Pharmaceutical, Inc. COLL 23.19 +0.04%
- Tilray Brands, Inc. TLRY 3.04 −5.30%
Collegium Pharmaceutical, Inc. and Tilray Brands, Inc. are both Drug Manufacturers Specialty & Generic companies. Collegium Pharmaceutical, Inc. is the larger, with a market value of $754.6M against $474.4M — 1.6× the size. Tilray Brands, Inc. has negative trailing earnings, so its P/E is not meaningful; Collegium Pharmaceutical, Inc. trades at 15.2×. Tilray Brands, Inc. grew revenue faster over the last twelve months: 15.9% against 14.3%. Collegium Pharmaceutical, Inc. has the higher net margin (5.93% vs −17.1%) and the higher return on invested capital (7.85% vs −3.21%). Across the 19 metrics below, Collegium Pharmaceutical, Inc. leads on 12 and Tilray Brands, Inc. on 7.
Valuation
Profitability
| Metric | COLL | TLRY | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 60.02% | 29.12% | 53.94% |
| Operating margin | 19.48% | (9.26%) | 0.00% |
| Net margin | 5.93% | (17.05%) | 0.00% |
| Free cash flow margin | 40.62% | (18.11%) | 0.00% |
| Return on equity | 17.61% | (10.50%) | (0.40%) |
| Return on assets | 2.57% | (7.45%) | (3.32%) |
| Return on invested capital | 7.85% | (3.21%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack